Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.0 replaces Revision: v3.4.3 in the record history.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice and the Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated system revision to v3.4.1 (from v3.4.0).SummaryDifference0.3%

- Check56 days agoChange DetectedGlossary toggle added and color-coded diff indicators introduced. The revision tag updated to v3.4.0, and the No FEAR Act label was updated (added as 'No FEAR Act Data' and the older 'No FEAR Act data' label removed).SummaryDifference0.4%

- Check71 days agoChange DetectedThe page history now shows a new revision: v3.3.4, and the previous revision v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.